| Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer J Yu, Q Feng, SH Wong, D Zhang, Q yi Liang, Y Qin, L Tang, H Zhao, ... Gut 66 (1), 70-78, 2017 | 944 | 2017 |
| Gut mucosal microbiome across stages of colorectal carcinogenesis G Nakatsu, X Li, H Zhou, J Sheng, SH Wong, WKK Wu, SC Ng, H Tsoi, ... Nature communications 6 (1), 8727, 2015 | 631 | 2015 |
| A catalog of the mouse gut metagenome L Xiao, Q Feng, S Liang, SB Sonne, Z Xia, X Qiu, X Li, H Long, J Zhang, ... Nature biotechnology 33 (10), 1103-1108, 2015 | 495 | 2015 |
| Novel recurrently mutated genes and a prognostic mutation signature in colorectal cancer J Yu, WKK Wu, X Li, J He, XX Li, SSM Ng, C Yu, Z Gao, J Yang, M Li, ... Gut 64 (4), 636-645, 2015 | 300 | 2015 |
| Fecal bacteria act as novel biomarkers for noninvasive diagnosis of colorectal cancer Q Liang, J Chiu, Y Chen, Y Huang, A Higashimori, J Fang, H Brim, ... Clinical Cancer Research 23 (8), 2061-2070, 2017 | 291 | 2017 |
| A novel faecal Lachnoclostridium marker for the non-invasive diagnosis of colorectal adenoma and cancer JQ Liang, T Li, G Nakatsu, YX Chen, TO Yau, E Chu, S Wong, CH Szeto, ... Gut 69 (7), 1248-1257, 2020 | 208 | 2020 |
| Dietary cholesterol promotes steatohepatitis related hepatocellular carcinoma through dysregulated metabolism and calcium signaling JQ Liang, N Teoh, L Xu, S Pok, X Li, ESH Chu, J Chiu, L Dong, E Arfianti, ... Nature Communications 9 (1), 4490, 2018 | 168 | 2018 |
| Genome‐wide identification of Epstein‐Barr virus–driven promoter methylation profiles of human genes in gastric cancer cells J Zhao, Q Liang, KF Cheung, W Kang, RWM Lung, JHM Tong, KF To, ... Cancer 119 (2), 304-312, 2013 | 166 | 2013 |
| Discovery of biclonal origin and a novel oncogene SLC12A5 in colon cancer by single-cell sequencing C Yu, J Yu, X Yao, WKK Wu, Y Lu, S Tang, X Li, L Bao, X Li, Y Hou, R Wu, ... Cell research 24 (6), 701-712, 2014 | 143 | 2014 |
| Targeting of YAP1 by microRNA-15a and microRNA-16-1 exerts tumor suppressor function in gastric adenocarcinoma W Kang, JHM Tong, RWM Lung, Y Dong, J Zhao, Q Liang, L Zhang, ... Molecular cancer 14, 1-10, 2015 | 127 | 2015 |
| Integrative identification of Epstein–Barr virus–associated mutations and epigenetic alterations in gastric cancer Q Liang, X Yao, S Tang, J Zhang, TO Yau, X Li, CM Tang, W Kang, ... Gastroenterology 147 (6), 1350-1362. e4, 2014 | 126 | 2014 |
| Zinc-finger protein 331, a novel putative tumor suppressor, suppresses growth and invasiveness of gastric cancer J Yu, QY Liang, J Wang, Y Cheng, S Wang, TCW Poon, MYY Go, Q Tao, ... Oncogene 32 (3), 307-317, 2013 | 118 | 2013 |
| A global burden of gastric cancer: the major impact of China Y Nie, K Wu, J Yu, Q Liang, X Cai, Y Shang, J Zhou, K Pan, L Sun, J Fang, ... Expert review of gastroenterology & hepatology 11 (7), 651-661, 2017 | 116 | 2017 |
| MicroRNA-18a attenuates DNA damage repair through suppressing the expression of ataxia telangiectasia mutated in colorectal cancer CW Wu, YJ Dong, QY Liang, XQ He, SSM Ng, FKL Chan, JJY Sung, J Yu PloS one 8 (2), e57036, 2013 | 106 | 2013 |
| Hepatic cyclooxygenase-2 overexpression induced spontaneous hepatocellular carcinoma formation in mice H Chen, W Cai, ESH Chu, J Tang, CC Wong, SH Wong, W Sun, Q Liang, ... Oncogene 36 (31), 4415-4426, 2017 | 104 | 2017 |
| CLDN3 inhibits cancer aggressiveness via Wnt-EMT signaling and is a potential prognostic biomarker for hepatocellular carcinoma L Jiang, YD Yang, L Fu, W Xu, D Liu, Q Liang, X Zhang, L Xu, XY Guan, ... Oncotarget 5 (17), 7663, 2014 | 98 | 2014 |
| Peroxisome proliferator activated receptor alpha inhibits hepatocarcinogenesis through mediating NF-κB signaling pathway N Zhang, ESH Chu, J Zhang, X Li, Q Liang, J Chen, M Chen, N Teoh, ... Oncotarget 5 (18), 8330, 2014 | 92 | 2014 |
| MDGA2 is a novel tumour suppressor cooperating with DMAP1 in gastric cancer and is associated with disease outcome K Wang, Q Liang, X Li, H Tsoi, J Zhang, H Wang, MYY Go, PWY Chiu, ... Gut 65 (10), 1619-1631, 2016 | 69 | 2016 |
| MicroRNA-20a in human faeces as a non-invasive biomarker for colorectal cancer TO Yau, CW Wu, CM Tang, Y Chen, J Fang, Y Dong, Q Liang, SSM Ng, ... Oncotarget 7 (2), 1559, 2016 | 62 | 2016 |
| Differentiated tumor immune microenvironment of Epstein–Barr virus-associated and negative gastric cancer: Implication in prognosis and immunotherapy J Ma, J Li, Y Hao, Y Nie, Z Li, M Qian, Q Liang, J Yu, M Zeng, K Wu Oncotarget 8 (40), 67094, 2017 | 60 | 2017 |
